GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (OTCPK:BMYMP.PFD) » Definitions » Stock Based Compensation

Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Stock Based Compensation : $529.00 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Bristol-Myers Squibb Co Stock Based Compensation?

Bristol-Myers Squibb Co's Stock Based Compensation for the three months ended in Mar. 2024 was $133.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was $529.00 Mil.


Bristol-Myers Squibb Co Stock Based Compensation Historical Data

The historical data trend for Bristol-Myers Squibb Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Stock Based Compensation Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 441.00 779.00 583.00 457.00 518.00

Bristol-Myers Squibb Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 122.00 137.00 132.00 127.00 133.00

Bristol-Myers Squibb Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $529.00 Mil.


Bristol-Myers Squibb Co Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Business Description

Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Headlines